SEC Form D private-offering filing

EtiraRX, Inc.

A new SEC Form D private-offering notice from Dallas, TX, a $3,000,003 filer-stated offering target in Biotech. The source filing is one click away.

EtiraRX, Inc. site↗ Verified via SEC Form D

Develops investigational cancer therapies targeting tumor heterogeneity in metastatic breast, ovarian, pancreatic, endometrial and hepatocellular cancers

Filed 2026-05-14Filed to raise $3,000,003First money in 2026-04-17Raised so far $2,277,533HQ (as filed) Dallas, TXSector Biotech ✓Stage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified etira.life↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.